机译:II,II和III型干扰素对直接作用抗病性丙型肝炎病毒的抗病毒作用评价
Department of Biopharmaceutics and Drug Metabolism Graduate School of Pharmaceutical Sciences;
Department of Biopharmaceutics and Drug Metabolism Graduate School of Pharmaceutical Sciences;
Department of Gastroenterology and Metabolism Programs for Biomedical Research Graduate School of;
Department of Biopharmaceutics and Drug Metabolism Graduate School of Pharmaceutical Sciences;
Department of Gastroenterology and Metabolism Programs for Biomedical Research Graduate School of;
Department of Gastroenterology and Metabolism Programs for Biomedical Research Graduate School of;
Department of Biopharmaceutics and Drug Metabolism Graduate School of Pharmaceutical Sciences;
Hepatitis C; Interferon; Direct-acting antiviral; Resistant;
机译:II,II和III型干扰素对直接作用抗病性丙型肝炎病毒的抗病毒作用评价
机译:乙型肝炎病毒感染肝细胞I型和III干扰素介导的抗病毒效果的比较分析
机译:通过与细胞培养的抗miR-122疗法组合有效预防直接作用抗病抗性丙型肝炎病毒
机译:HLA-C基因在丙型肝炎病毒中感染埃及患者,估计HLA-C基因和干扰素/利巴韦林与丙型肝炎病毒治疗的关系
机译:在直接作用抗病毒中,美国乙型肝炎病毒感染患者的医疗资源利用率,住院死亡率和风险行为
机译:接受慢性丙型肝炎病毒感染的无干扰素直接作用抗病毒药物的患者中的乙肝病毒激活
机译:丙型肝炎病毒和III型干扰素(interferon-λ3/ interleukin-28B和interferon-λ4):易感性和对抗病毒治疗反应的遗传基础。